Biliary Tract Carcinoma — Trials

Biliary Tract Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

823 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 238
Recruiting: 138
Ph III recruiting: 9
Growth YoY: +12.7%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (111)

clinicaltrialsPublishedShowing 151–153 of 153 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00350961	Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma	completed	Phase 1 / Phase 2	39	Rigshospitalet, DenmarkOTHER	1	Aug 26, 2008	clinicaltrials
NCT00160836	Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter	unknown	Phase 1	68	University Hospital, GenevaOTHER	1	Apr 19, 2007	clinicaltrials